| 产品描述： | Enfuvirtide (T20;DP178) is an anti-HIV-1 fusion inhibitor peptide. |
| 靶点： |
HIV-1;HIVProtease |
| 体内研究： |
Enfuvirtide has a T1/2 of 3.8 h |
| 参考文献： |
1. Figueira TN, et al. Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance. Sci Rep. 2017 Mar 30;7:45647. 2. Cao P, et al. The improved efficacy of Sifuvirtide compared with Enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance. PLoS One. 2017 Feb 16;12(2):e0171567. 3. Wang X, et al. IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages. Front Immunol. 2017 Mar 6;8:210. |
| 溶解性： |
DMSO : 20 mg/mL (4.45 mM; Need ultrasonic) H2O : 0.67 mg/mL (0.15 mM; Need ultrasonic) |
| 保存条件： |
-20°C |
| 配置溶液浓度参考： |
|
1mg |
5mg |
10mg |
| 1 mM |
0.223 ml |
1.113 ml |
2.226 ml |
| 5 mM |
0.045 ml |
0.223 ml |
0.445 ml |
| 10 mM |
0.022 ml |
0.111 ml |
0.223 ml |
| 50 mM |
0.004 ml |
0.022 ml |
0.045 ml |
|
| 注意： |
部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京